PSMD1 and COVID-19: The M12 anti-S1 GMCs did not statistically significantly differ by overall infection severity when analysed as an ordinal variable (p = 0.566), and this remained the case after stratifying by the number of COVID-19 vaccine doses received (Table 2, Figure 2J,K).